SAN FRANCISCO, Oct. 29, 2021 (GLOBE NEWSWIRE) — PepperLime Health Acquisition Corporation (the “Company”), a Cayman Islands exempted firm that could be a clean examine firm fashioned for the aim of getting into right into a merger, share alternate, asset acquisition, share buy, reorganization or comparable business mixture with a number of companies, immediately introduced the closing of the issuance of two,000,000 models pursuant to the partial train of the underwriters’ choice to buy extra models in reference to the Company’s beforehand introduced preliminary public providing. The extra models had been offered at $10.00 per unit, leading to gross proceeds of $20,000,000 and bringing the entire gross proceeds from the Company’s preliminary public providing to $170,000,000, earlier than deducting underwriting reductions and commissions and different providing bills payable by the Company.
While the Company could pursue an preliminary business mixture goal in any business or business, the Company intends to focus on corporations on the intersection of know-how and shopper well being and wellness. The extra proceeds from the train of the over-allotment possibility might be used to fund the business mixture.
The models started buying and selling on the Nasdaq Global Market below the ticker image “PEPLU” on Oct. 15, 2021. Each unit consists of 1 Class A extraordinary share of the Company and one-half of 1 warrant. Each entire warrant entitles the holder thereof to buy one Class A extraordinary share of the Company at a value of $11.50 per share. Once the securities comprising the models start separate buying and selling, the Class A extraordinary shares and warrants are anticipated to be listed on the Nasdaq Global Market below the symbols “PEPL” and “PEPLW,” respectively.
Oppenheimer & Co. Inc. acted as the only underwriter for the providing.
The providing was made solely by way of a prospectus. A replica of the ultimate prospectus associated to the providing could also be obtained from: Oppenheimer & Co. Inc., Attn: Syndicate Prospectus Department, 85 Broad Street, twenty sixth Floor, New York, New York 10004, phone: (212) 667-8055 or e mail: [email protected].
A registration assertion referring to the providing has been filed with, and declared efficient by, the U.S. Securities and Exchange Commission (the “SEC”) on Oct. 14, 2021. Copies of the registration assertion, as amended, might be accessed via the SEC’s web site at www.sec.gov. This press launch shall not represent a proposal to promote or the solicitation of a proposal to purchase, nor shall there be any sale of those securities in any state or jurisdiction through which such supply, solicitation, or sale could be illegal previous to registration or qualification below the securities legal guidelines of any such state or jurisdiction.
This press launch accommodates statements that represent “forward-looking statements,” together with with respect to the anticipated use of the online proceeds. No assurance might be provided that the online proceeds of the providing might be used as indicated. Forward-looking statements are topic to quite a few circumstances, lots of that are past the management of the Company, together with these set forth within the Risk Factors part of the Company’s registration assertion and any prospectus for the Company’s providing filed with the SEC. Copies can be found on the SEC’s web site, www.sec.gov. The Company undertakes no obligation to replace these statements for revisions or modifications after the date of this launch, besides as required by legislation.
Contact
PepperLime Health Acquisition Corporation
www.pepperlimehealth.com
Ramzi Haidamus
(415) 263-9939
Related Images
Image 1
This content material was issued via the press launch distribution service at Newswire.com.
- Featured Image for PepperLime Health
